Zeng, Hongmei
Sun, Kexin
Cao, Maomao
Zheng, Rongshou
Sun, Xibin
Liu, Shuzheng
Zhang, Zhiyi
Liu, Yuqin
Guo, Guizhou
Song, Guohui
Zhu, Yigong
Wu, Xianghong
Song, Bingbing
Liao, Xianzhen
Chen, Yanfang
Song, Mingyang
Giovannucci, Edward
Zhuang, Guihua
Wei, Wenqiang
Chen, Wanqing
He, Jie
Clinical trials referenced in this document:
Documents that mention this clinical trial
Funding for this research was provided by:
Special Fund for Health Research in the Public Interest (201502001)
National Natural Science Foundation of China (81672819)
National Key R&D Program of China (2018YFC1313100)
Article History
Received: 31 May 2020
Accepted: 29 October 2020
First Online: 24 November 2020
Ethics approval and consent to participate
: The present study has been approved by the independent ethics committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Every eligible participant signed written consents before doing investigation and when receiving endoscope in the screening if necessary. The gatekeepers and participating individuals were informed about all study arms. The study adheres to CONSORT guidelines and include a completed CONSORT checklist as shown in supplement.
: All named authors have agreed to the paper publication.
: The authors have declared no conflicts of interest.